Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel R Altmann

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Neurology|August 31, 2015
Motor network efficiency and disability in multiple sclerosisMatteo Pardini, Özgür Yaldizli, Varun Sethi, et al.
The Lancet. Neurology|July 10, 2007
MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective studyJosephine K Swanton, Alex Rovira, Mar Tintore, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 11, 2019
A multi-shell multi-tissue diffusion study of brain connectivity in early multiple sclerosisCarmen Tur, Francesco Grussu, Ferran Prados, et al.
Biological Psychiatry|May 11, 2010
Changes in the frontotemporal cortex and cognitive correlates in first-episode psychosisLeticia Gutiérrez-Galve, Claudia A M Wheeler-Kingshott, Daniel R Altmann, et al.
Neuroimage. Clinical|January 22, 2016
Fully automated segmentation of the cervical cord from T1-weighted MRI using PropSeg: Application to multiple sclerosisMarios C Yiannakas, Ahmed M Mustafa, Benjamin De Leener, et al.
The Lancet. Neurology|January 13, 2012
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept studyPeter Connick, Madhan Kolappan, Charles Crawley, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 25, 2019
Single-subject structural cortical networks in clinically isolated syndromeSara Collorone, Ferran Prados, Marloes Hj Hagens, et al.
The Lancet. Neurology|January 30, 2016
Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trialRhian Raftopoulos, Simon J Hickman, Ahmed Toosy, et al.
Annals of Clinical and Translational Neurology|September 18, 2022
Remyelination varies between and within lesions in multiple sclerosis following bexaroteneJ William L Brown, Ferran Prados, Daniel R Altmann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 26, 2022
Multimodal Analysis of the Visual Pathways in Friedreich's Ataxia Reveals Novel BiomarkersGilbert Thomas-Black, Daniel R Altmann, Harry Crook, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Neurology|August 31, 2015
Motor network efficiency and disability in multiple sclerosisMatteo Pardini, Özgür Yaldizli, Varun Sethi, et al.
The Lancet. Neurology|July 10, 2007
MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective studyJosephine K Swanton, Alex Rovira, Mar Tintore, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 11, 2019
A multi-shell multi-tissue diffusion study of brain connectivity in early multiple sclerosisCarmen Tur, Francesco Grussu, Ferran Prados, et al.
Biological Psychiatry|May 11, 2010
Changes in the frontotemporal cortex and cognitive correlates in first-episode psychosisLeticia Gutiérrez-Galve, Claudia A M Wheeler-Kingshott, Daniel R Altmann, et al.
Neuroimage. Clinical|January 22, 2016
Fully automated segmentation of the cervical cord from T1-weighted MRI using PropSeg: Application to multiple sclerosisMarios C Yiannakas, Ahmed M Mustafa, Benjamin De Leener, et al.
The Lancet. Neurology|January 13, 2012
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept studyPeter Connick, Madhan Kolappan, Charles Crawley, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 25, 2019
Single-subject structural cortical networks in clinically isolated syndromeSara Collorone, Ferran Prados, Marloes Hj Hagens, et al.
The Lancet. Neurology|January 30, 2016
Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trialRhian Raftopoulos, Simon J Hickman, Ahmed Toosy, et al.
Annals of Clinical and Translational Neurology|September 18, 2022
Remyelination varies between and within lesions in multiple sclerosis following bexaroteneJ William L Brown, Ferran Prados, Daniel R Altmann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 26, 2022
Multimodal Analysis of the Visual Pathways in Friedreich's Ataxia Reveals Novel BiomarkersGilbert Thomas-Black, Daniel R Altmann, Harry Crook, et al.
Pageof 6